Longitudinal monitoring of bone measured by quantitative multisite ultrasound in patients with Crohn's disease

被引:0
|
作者
Zadik, Z [1 ]
Sinai, T
Zung, A
Reifen, R
机构
[1] Hebrew Univ Jerusalem, Hadassah Med Sch, Kaplan Med Ctr, Pediat Endocrine Unit, IL-76100 Rehovot, Israel
[2] Hebrew Univ Jerusalem, Sch Nutr Sci, IL-76100 Rehovot, Israel
关键词
Crohn's disease; bone density; oxandrolone;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Crohn's disease (CD) is characterized, among other features, by intestinal malabsorption of minerals, vitamins, and various food ingredients. This may cause a suboptimal peak bone mass and thereby susceptibility to osteoporosis at an early age. Objective: Longitudinal measurement of bone in CD during active disease and during remission. Design: We evaluated 24 patients with CD (16 males) 14 to 16 years of age longitudinally, every 3 months over 12 months, for disease activity. Longitudinal follow-up by quantitative ultrasound measurement using a bone sonometer (Sunlight Omnisense, Tel Aviv, Israel) that obtains axial speed of sound (SOS) was also performed. Eight of the CD patients were in remission (R-CD), characterized by accelerated weight and height gain and near-normal erythrocyte sedimentation rate and serum iron. Eight patients had active CD (A-CD), and 8 patients were under treatment with oxandrolone. Results: By two-way repeated-measures analysis of variance, the change in SOS Z-score of tibia at 0, 6, and 12 months was as follows: -0.5 +/- 0.2 to -0.3 +/- 0.2, -0.6 +/- 0.2 to -1.0 +/- 0. 5 and - 0.6 +/- 0.2 to -0.4 +/- 0.2 in the remission, active disease, and oxandrolone-treated groups, respectively (P < 0.001). Similarly, the change in SOS Z-score of radius during the study was as follows: - 0.5 +/- 0.3 to -0.6 +/- 0.3, -0.6 +/- 0.3 to -1.0 +/- 0.3 and -0.6 +/- 0.2 to -0.4 +/- 0.2 in the remission, active disease, and oxandrolone-treated groups, respectively (P < 0.001). While a small change over time in patients in remission was noted, SOS decreased in patients with active disease and increased in oxandrolone-treated patients. Despite the fact that SOS remained in the normative range in all patients, a clear deterioration was demonstrated for patients with active disease. Conclusions: We conclude that longitudinal follow-up of patients with active disease may detect an early pattern of deterioration in quality of bone.
引用
收藏
页码:120 / 123
页数:4
相关论文
共 50 条
  • [31] QUANTITATIVE CONTRAST-ENHANCED ULTRASOUND COMPARISON BETWEEN INFLAMMATORY AND FIBROTIC LESIONS IN PATIENTS WITH CROHN'S DISEASE
    Nylund, Kim
    Jirik, Radovan
    Mezl, Martin
    Leh, Sabine
    Hausken, Trygve
    Pfeffer, Frank
    Odegaard, Svein
    Taxt, Torfinn
    Gilja, Odd Helge
    ULTRASOUND IN MEDICINE AND BIOLOGY, 2013, 39 (07): : 1197 - 1206
  • [32] Bowel ultrasound in Crohn's disease
    Maconi, G
    Radice, E
    Greco, S
    Porro, GB
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2006, 20 (01) : 93 - 112
  • [33] Therapeutic drug monitoring of methotrexate in patients with Crohn's disease
    van de Meeberg, Maartje M.
    Fidder, Herma H.
    Oldenburg, Bas
    Sundaresan, Janani
    Struys, Eduard A.
    Montazeri, Nahid S. M.
    Mares, Wout G. N.
    Mahmmod, Nofel
    van Asseldonk, Dirk P.
    Lutgens, Maurice W. M. D.
    Kuyvenhoven, Johan P.
    Rietdijk, Svend T.
    Nissen, Loes H. C.
    Koehestanie, Parweez
    de Boer, Nanne K. H.
    de Jonge, Robert
    Bouma, Gerd
    Calasan, Maja Bulatovic
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (11-12) : 1151 - 1162
  • [34] A Study on Bone Mineral Density in Patients with Crohn's Disease
    Oshima, Toshihiro
    Taira, Satoru
    Nonaka, Masaya
    Hayama, Yoshiki
    Yagi, Kenji
    Yukuwa, Ikuko
    Koh, Mari
    Kondo, Mari
    Kawakami, Kohei
    Kawai, Takashi
    Miyaoka, Masaaki
    Sakai, Yoshihiro
    Moriyasu, Fuminori
    Matsuoka, Hiroaki
    Yamamoto, Kengo
    HEPATO-GASTROENTEROLOGY, 2008, 55 (88) : 2116 - 2120
  • [35] Osteoporosis and determinants of bone density in patients with Crohn's disease
    Robinson, RJ
    Al Azzawi, F
    Iqbal, SJ
    Kryswcki, T
    Almond, L
    Abrams, K
    Mayberry, JF
    DIGESTIVE DISEASES AND SCIENCES, 1998, 43 (11) : 2500 - 2506
  • [36] Osteoporosis and Determinants of Bone Density in Patients with Crohn's Disease
    R. J. Robinson
    F. Al Azzawi
    S. J. Iqbal
    T. Kryswcki
    L. Almond
    K. Abrams
    J. F. Mayberry
    Digestive Diseases and Sciences, 1998, 43 : 2500 - 2506
  • [37] Bowel ultrasound as an early monitoring tool to assess disease activity in Crohn's disease patients after induction therapy with infliximab
    Morao, B.
    Nascimento, C.
    Frias Gomes, C.
    Goncalves, T.
    Castro, F.
    Moreira, M. J.
    Cotter, J.
    Pereira, F.
    Caldeira, A.
    Sousa, R.
    Coelho, R.
    Macedo, G.
    Macedo, C.
    Ferreira, M.
    Cravo, M.
    Gloria, L.
    Torres, J.
    Palmela, C.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S232 - S232
  • [38] Quantitative assessment of ultrasound microvessel imaging in Crohn's disease: correlation with pathological inflammation
    Lok, U-Wai
    Tang, Shanshan
    Gong, Ping
    Smyrk, Thomas
    Huang, Chengwu
    Deruiter, Ryan M.
    Knoll, Kate M.
    Robinson, Kathryn A.
    Sheedy, Shannon P.
    Holmes, Philip M.
    Zhang, Jingke
    El Sadaney, Ahmed O.
    Harmsen, William
    Fletcher, Joel G.
    Knudsen, John M.
    Chen, Shigao
    Bruining, David H.
    EUROPEAN RADIOLOGY, 2024,
  • [39] Role of parietal healing by ultrasound in the evolution of patients with Crohn's disease
    Mayor Delgado, P.
    Suarez Ferrer, C. J.
    Poza Cordon, J.
    Martin Arranz, E.
    Rueda Garcia, J. L.
    Sanchez Azofra, M.
    Cuadros Martinez, M.
    Ruiz Ramirez, M. A.
    Martin Arranz, M. D.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S304 - S305
  • [40] Usefulness of Doppler ultrasound in the evaluation of patients with active Crohn's disease
    Delgado, MS
    Pedregal, CJ
    Blanco, JAP
    Gonzalez, MB
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 1997, 89 (09) : 681 - 684